Trial · NCT00307047
Outcomes66
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 66
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| SECONDARY | Ischemia Driven Target Vessel Failure (TVF) | 30 days | percentage of participants | NUMBER | |
| SECONDARY | Ischemia Driven Target Vessel Failure (TVF) | 180 days | percentage of participants | NUMBER | |
| SECONDARY | Ischemia Driven Target Vessel Failure (TVF) | 270 days | percentage of participants | NUMBER | |
| SECONDARY | Ischemia Driven Target Vessel Failure (TVF) | 1 year | ITT, @ 1 yr | percentage of participants | NUMBER |
| SECONDARY | Ischemia Driven Target Vessel Failure (TVF) | 2 years | ITT, @ 2 years | percentage of participants | NUMBER |
| SECONDARY | Ischemia Driven Target Vessel Failure (TVF) | 3 years | ITT, @ 3 years | percentage of participants | NUMBER |
| SECONDARY | Ischemia Driven Target Lesion Revascularization (TLR) | 30 days | ITT population. | percentage of participants | NUMBER |
| SECONDARY | Ischemia Driven Target Lesion Revascularization (TLR) | 180 days | ITT population | percentage of participants | NUMBER |
| SECONDARY | Ischemia Driven Target Lesion Revascularization (TLR) | 270 days | ITT population | percentage of participants | NUMBER |
| SECONDARY | Ischemia Driven Target Lesion Revascularization (TLR) | 1 year | ITT population. | percentage of participants | NUMBER |
| SECONDARY | Ischemia Driven Target Lesion Revascularization (TLR) | 2 years | ITT population. | percentage of participants | NUMBER |
| SECONDARY | Ischemia Driven Target Lesion Revascularization (TLR) | 3 years | ITT population. | percentage of participants | NUMBER |
| SECONDARY | Ischemia Driven Target Vessel Revascularization (TVR) | 30 days | percentage of participants | NUMBER | |
| SECONDARY | Ischemia Driven Target Vessel Revascularization (TVR) | 180 days | percentage of participants | NUMBER | |
| SECONDARY | Ischemia Driven Target Vessel Revascularization (TVR) | 270 days | percentage of participants | NUMBER | |
| SECONDARY | Ischemia Driven Target Vessel Revascularization (TVR) | 1 year | percentage of participants | NUMBER | |
| SECONDARY | Ischemia Driven Target Vessel Revascularization (TVR) | 2 years | percentage of participants | NUMBER | |
| SECONDARY | Ischemia Driven Target Vessel Revascularization (TVR) | 3 years | percentage of participants | NUMBER | |
| SECONDARY | Ischemia Driven Major Adverse Cardiac Events (MACE) | 30 days | Percentage of participants | NUMBER | |
| SECONDARY | Ischemia Driven Major Adverse Cardiac Events (MACE) | 180 days | Percentage of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00307047/outcomes